Group O human immunodeficiency virus-1 infections (Q41717707)

7 October 2017

1 reference

title

Group O human immunodeficiency virus-1 infections (English)

1 reference

7 October 2017

Jaffe HW

1

1 reference

7 October 2017

Schochetman G

series ordinal

2

1 reference

7 October 2017

publication date

1 March 1998

1 reference

Infectious Disease Clinics of North America

7 October 2017

published in

1 reference

7 October 2017

volume

12

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

39-46

1 reference

Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Sequence of gp41env immunodominant region of HIV type 1 group O from west central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Genetic variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Structure, Replication, and Recombination of Retrovirus Genomes: Some Unifying Hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

HIV-1 group O and group M dual infection in Bénin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

In Vivo Sequence Variation of the Human Immunodeficiency Virus Type 1envGene: Evidence for Recombination Among Variants Found in a Single Individual

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Diagnosis of HIV-1 group O infection by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Serological and virological characterization of HIV-1 group O infection in Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Tenth anniversary perspectives on AIDS. HIV: between past and future

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Geographical distribution of HIV-1 group O viruses in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

HIV-1 group O virus identified for the first time in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Recombination in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Sensitivity of screening kits for anti-HIV-1 subtype O antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Triple HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Evaluation of a new third generation anti-HIV-1/anti-HIV-2 assay with increased sensitivity for HIV-1 group O

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

HIV Type 1 Variation in World Health Organization-Sponsored Vaccine Evaluation Sites: Genetic Screening, Sequence Analysis, and Preliminary Biological Characterization of Selected Viral Strains

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970407-4

7 January 2021

10.1016/S0891-5520(05)70407-4

Identifiers

DOI

1 reference

7 October 2017

1 reference